Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CEO Urges $31 Million Investment In Malaysia Biotech Sector

This article was originally published in PharmAsia News

Executive Summary

A biotech CEO says Malaysia needs as much as $31 million in public-sector investment within the next three years if the industry is to reach a commercialization level. Datuk Iskandar Mizal Mahmood, CEO of Malaysian Biotech, spoke of a need of $25 million to $31 million to build an infrastructure and collaborate with foreign entities to leverage the nation's tissue-banking sector. He said Malaysia needs to make a strong effort to complement the efforts of the National Tissue Bank and Nuklear Malaysia to commercialize tissue banking as part of a huge global market for tissue-engineered products. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts